| 1. Kansy M, Senner F, Gubernator K.. (1998) Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes., 41 (7): [PMID:9544199] [10.1021/jm970530e] |
| 2. Dunn WJ, Koehler MG, Grigoras S.. (1987) The role of solvent-accessible surface area in determining partition coefficients., 30 (7): [PMID:3599019] [10.1021/jm00390a002] |
| 3. Jorgensen WL, Duffy EM.. (2000) Prediction of drug solubility from Monte Carlo simulations., 10 (11): [PMID:10866370] [10.1016/s0960-894x(00)00172-4] |
| 4. Ojasoo T, Doré JC, Gilbert J, Raynaud JP.. (1988) Binding of steroids to the progestin and glucocorticoid receptors analyzed by correspondence analysis., 31 (6): [PMID:2897467] [10.1021/jm00401a015] |
| 5. Lombardo F, Obach RS, Shalaeva MY, Gao F.. (2004) Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics., 47 (5): [PMID:14971904] [10.1021/jm030408h] |
| 6. Stiefl N, Baumann K.. (2003) Mapping property distributions of molecular surfaces: algorithm and evaluation of a novel 3D quantitative structure-activity relationship technique., 46 (8): [PMID:12672239] [10.1021/jm021077w] |
| 7. Honda T, Finlay HJ, Gribble GW, Suh N, Sporn MB. (1997) New enone derivatives of oleanolic acid and ursolic acid as inhibitors of nitric oxide production in mouse macrophages, 7 (13): [10.1016/S0960-894X(97)00279-5] |
| 8. Schwab D, Fischer H, Tabatabaei A, Poli S, Huwyler J.. (2003) Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery., 46 (9): [PMID:12699389] [10.1021/jm021012t] |
| 9. Haviv F, Ratajczyk JD, DeNet RW, Kerdesky FA, Walters RL, Schmidt SP, Holms JH, Young PR, Carter GW.. (1988) 3-[1-(2-Benzoxazolyl)hydrazino]propanenitrile derivatives: inhibitors of immune complex induced inflammation., 31 (9): [PMID:2970549] [10.1021/jm00117a010] |
| 10. Suomalainen P, Johans C, Söderlund T, Kinnunen PK.. (2004) Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability., 47 (7): [PMID:15027870] [10.1021/jm0309001] |
| 11. Suomalainen P, Johans C, Söderlund T, Kinnunen PK.. (2004) Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability., 47 (7): [PMID:15027870] [10.1021/jm0309001] |
| 12. Honda T, Gribble GW, Suh N, Finlay HJ, Rounds BV, Bore L, Favaloro FG, Wang Y, Sporn MB.. (2000) Novel synthetic oleanane and ursane triterpenoids with various enone functionalities in ring A as inhibitors of nitric oxide production in mouse macrophages., 43 (9): [PMID:10794703] [10.1021/jm000008j] |
| 13. Selassie CD, Hansch C, Khwaja TA.. (1990) Structure-activity relationships of antineoplastic agents in multidrug resistance., 33 (7): [PMID:2362268] [10.1021/jm00169a014] |
| 14. Stenberg P, Norinder U, Luthman K, Artursson P.. (2001) Experimental and computational screening models for the prediction of intestinal drug absorption., 44 (12): [PMID:11384238] [10.1021/jm001101a] |
| 15. Sugiyama N, Akahoshi F, Kuwahara S, Kajii M, Sakaue Y, Yakumaru H, Sugiura M, Fukaya C.. (1994) Synthesis and topical antiinflammatory and antiallergic activities of antioxidant o-aminophenol derivatives., 37 (13): [PMID:7913134] [10.1021/jm00039a010] |
| 16. Stouch TR, Jurs PC.. (1986) Computer-aided studies of the structure-activity relationships between the structure of some steroids and their antiinflammatory activity., 29 (11): [PMID:3783574] [10.1021/jm00161a001] |
| 17. Silverman BD, Platt DE.. (1996) Comparative molecular moment analysis (CoMMA): 3D-QSAR without molecular superposition., 39 (11): [PMID:8667357] [10.1021/jm950589q] |
| 18. Matsuda H, Murakami T, Ninomiya K, Inadzuki M, Yoshikawa M. (1997) New hepatoprotective saponins, bupleurosides III, VI, IX, and XIII, from Chinese Bupleuri Radix: Structure-requirements for the cytoprotective activity in primary cultured rat hepatocytes, 7 (17): [10.1016/S0960-894X(97)00418-6] |
| 19. Matsuda H, Shimoda H, Yamahara J, Yoshikawa M.. (1998) Immunomodulatory activity of thunberginol A and related compounds isolated from Hydrangeae Dulcis Folium on splenocyte proliferation activated by mitogens., 8 (3): [PMID:9871657] [10.1016/s0960-894x(97)10221-9] |
| 20. Crivori P, Cruciani G, Carrupt PA, Testa B.. (2000) Predicting blood-brain barrier permeation from three-dimensional molecular structure., 43 (11): [PMID:10841799] [10.1021/jm990968+] |
| 21. Haviv F, DeNet RW, Michaels RJ, Ratajczyk JD, Carter GW, Young PR.. (1983) 2-[(Phenylthio)methyl]pyridine derivatives: new antiinflammatory agents., 26 (2): [PMID:6827539] [10.1021/jm00356a018] |
| 22. Jain AN, Koile K, Chapman D.. (1994) Compass: predicting biological activities from molecular surface properties. Performance comparisons on a steroid benchmark., 37 (15): [PMID:8057280] [10.1021/jm00041a010] |
| 23. Lombardo F, Shalaeva MY, Tupper KA, Gao F.. (2001) ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds., 44 (15): [PMID:11448232] [10.1021/jm0100990] |
| 24. Kubinyi H, Hamprecht FA, Mietzner T.. (1998) Three-dimensional quantitative similarity-activity relationships (3D QSiAR) from SEAL similarity matrices., 41 (14): [PMID:9651159] [10.1021/jm970732a] |
| 25. Kotani T, Higashiura K.. (2004) Comparative molecular active site analysis (CoMASA). 1. An approach to rapid evaluation of 3D QSAR., 47 (11): [PMID:15139751] [10.1021/jm030364c] |
| 26. Lombardo F, Shalaeva MY, Tupper KA, Gao F, Abraham MH.. (2000) ElogPoct: a tool for lipophilicity determination in drug discovery., 43 (15): [PMID:10956200] [10.1021/jm0000822] |
| 27. Good AC, Peterson SJ, Richards WG.. (1993) QSAR's from similarity matrices. Technique validation and application in the comparison of different similarity evaluation methods., 36 (20): [PMID:8411009] [10.1021/jm00072a012] |
| 28. Crippen GM.. (1997) Validation of EGSITE2, a mixed integer program for deducing objective site models for experimental binding data., 40 (20): [PMID:9379435] [10.1021/jm970211n] |
| 29. Pastor M, Cruciani G, McLay I, Pickett S, Clementi S.. (2000) GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors., 43 (17): [PMID:10966742] [10.1021/jm000941m] |
| 30. Farr CD, Tabet MR, Ball WJ, Fishwild DM, Wang X, Nair AC, Welsh WJ.. (2002) Three-dimensional quantitative structure-activity relationship analysis of ligand binding to human sequence antidigoxin monoclonal antibodies using comparative molecular field analysis., 45 (15): [PMID:12109909] [10.1021/jm0102811] |
| 31. Bodor N, Harget AJ, Phillips EW.. (1983) Structure-activity relationships in the antiinflammatory steroids: a pattern-recognition approach., 26 (3): [PMID:6827553] [10.1021/jm00357a003] |
| 32. Kumar V, Bell MR, Wetzel JR, Herrmann JL, McGarry R, Schane HP, Winneker RC, Snyder BW, Anzalone AJ.. (1993) Non-steroidal glucocorticoid-like substances: receptor binding and in vivo activity., 36 (22): [PMID:8230118] [10.1021/jm00074a008] |
| 33. Honda T, Rounds BV, Bore L, Favaloro FG, Gribble GW, Suh N, Wang Y, Spor MB.. (1999) Novel synthetic oleanane triterpenoids: a series of highly active inhibitors of nitric oxide production in mouse macrophages., 9 (24): [PMID:10617085] [10.1016/s0960-894x(99)00623-x] |
| 34. Matsuda H, Ninomiya K, Morikawa T, Yoshikawa M.. (1998) Inhibitory effect and action mechanism of sesquiterpenes from Zedoariae Rhizoma on D-galactosamine/lipopolysaccharide-induced liver injury., 8 (4): [PMID:9871681] [10.1016/s0960-894x(98)00021-3] |
| 35. Motohashi S, Akihisa T, Tamura T, Tokutake N, Takido M, Yasukawa K.. (1995) Alkane-6,8-diol: inhibitor of tumor promotion in two-stage carcinogenesis in mouse skin., 38 (21): [PMID:7473540] [10.1021/jm00021a002] |
| 36. Honda T, Rounds BV, Bore L, Finlay HJ, Favaloro FG, Suh N, Wang Y, Sporn MB, Gribble GW.. (2000) Synthetic oleanane and ursane triterpenoids with modified rings A and C: a series of highly active inhibitors of nitric oxide production in mouse macrophages., 43 (22): [PMID:11063620] [10.1021/jm0002230] |
| 37. So SS, Karplus M.. (1997) Three-dimensional quantitative structure-activity relationships from molecular similarity matrices and genetic neural networks. 1. Method and validations., 40 (26): [PMID:9435904] [10.1021/jm970487v] |
| 38. Shue HJ, Green MJ, Berkenkoph J, Monahan M, Fernandez X, Lutsky BN.. (1980) Synthesis and structure-activity studies of a series of 7 alpha-halogeno corticosteroids., 23 (4): [PMID:7381842] [10.1021/jm00178a015] |
| 39. Colmenarejo G, Alvarez-Pedraglio A, Lavandera JL.. (2001) Cheminformatic models to predict binding affinities to human serum albumin., 44 (25): [PMID:11728183] [10.1021/jm010960b] |
| 40. Good AC, So SS, Richards WG.. (1993) Structure-activity relationships from molecular similarity matrices., 36 (4): [PMID:8474098] [10.1021/jm00056a002] |
| 41. Jyrkkärinne J, Mäkinen J, Gynther J, Savolainen H, Poso A, Honkakoski P.. (2003) Molecular determinants of steroid inhibition for the mouse constitutive androstane receptor., 46 (22): [PMID:14561088] [10.1021/jm030861t] |
| 42. Favaloro FG, Honda T, Honda Y, Gribble GW, Suh N, Risingsong R, Sporn MB.. (2002) Design and synthesis of tricyclic compounds with enone functionalities in rings A and C: a novel class of highly active inhibitors of nitric oxide production in mouse macrophages., 45 (22): [PMID:12383005] [10.1021/jm025565f] |
| 43. Friend DR, Chang GW.. (1985) Drug glycosides: potential prodrugs for colon-specific drug delivery., 28 (1): [PMID:3965714] [10.1021/jm00379a012] |
| 44. Solo AJ, Tramposch KM, Szeto DW, Suto MJ.. (1982) Relative affinity of 17 alpha- and/or 21-esters and 17 alpha, 21-diesters of cortisol for a glucocorticoid receptor from rat thymocytes., 25 (6): [PMID:7097729] [10.1021/jm00348a027] |
| 45. Gossett LS, Habeck LL, Shackelford KA, Mendelsohn LG, Gates SB, Worzalla JF, Self TD, Theobald KS, Andis SL, Schultz RM, Shih C.. (1999) The synthesis and biological activity of a series of 2,4-diaminopyrido[2,3-d]pyrimidine based antifolates as antineoplastic and antiarthritic agents., 9 (1): [PMID:9990460] [10.1016/s0960-894x(98)00683-0] |
| 46. Kimura I, Yoshikawa M, Kobayashi S, Sugihara Y, Suzuki M, Oominami H, Murakami T, Matsuda H, Doiphode VV.. (2001) New triterpenes, myrrhanol A and myrrhanone A, from guggul-gum resins, and their potent anti-inflammatory effect on adjuvant-induced air-pouch granuloma of mice., 11 (8): [PMID:11327606] [10.1016/s0960-894x(01)00111-1] |
| 47. Wang YH, Li Y, Li YH, Yang SL, Yang L.. (2005) Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism., 15 (18): [PMID:15990295] [10.1016/j.bmcl.2005.06.015] |
| 48. Caron G, Ermondi G.. (2005) Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk)., 48 (9): [PMID:15857133] [10.1021/jm048980b] |
| 49. Lill MA, Winiger F, Vedani A, Ernst B.. (2005) Impact of induced fit on ligand binding to the androgen receptor: a multidimensional QSAR study to predict endocrine-disrupting effects of environmental chemicals., 48 (18): [PMID:16134935] [10.1021/jm050403f] |
| 50. Schuster D, Maurer EM, Laggner C, Nashev LG, Wilckens T, Langer T, Odermatt A.. (2006) The discovery of new 11beta-hydroxysteroid dehydrogenase type 1 inhibitors by common feature pharmacophore modeling and virtual screening., 49 (12): [PMID:16759088] [10.1021/jm0600794] |
| 51. Ottaviani G, Martel S, Carrupt PA.. (2006) Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability., 49 (13): [PMID:16789751] [10.1021/jm060230+] |
| 52. Kahn MG, Konde E, Dossou F, Labaree DC, Hochberg RB, Hoyte RM.. (2006) Microwave-enhanced nucleophilic fluorination in the synthesis of fluoropyridyl derivatives of [3,2-c]pyrazolo-corticosteroids, potential glucocorticoid receptor-mediated imaging agents., 16 (13): [PMID:16644222] [10.1016/j.bmcl.2006.04.008] |
| 53. Ulven T, Receveur JM, Grimstrup M, Rist Ø, Frimurer TM, Gerlach LO, Mathiesen JM, Kostenis E, Uller L, Högberg T.. (2006) Novel selective orally active CRTH2 antagonists for allergic inflammation developed from in silico derived hits., 49 (23): [PMID:17154491] [10.1021/jm060657g] |
| 54. Elkins CA, Mullis LB.. (2007) Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli., 51 (3): [PMID:17210767] [10.1128/aac.01048-06] |
| 55. Ukiya M, Akihisa T, Yasukawa K, Koike K, Takahashi A, Suzuki T, Kimura Y.. (2007) Triterpene glycosides from the flower petals of sunflower (Helianthus annuus) and their anti-inflammatory activity., 70 (5): [PMID:17480100] [10.1021/np078002l] |
| 56. Metwally KA, Yaseen SH, Lashine el-SM, El-Fayomi HM, El-Sadek ME.. (2007) Non-carboxylic analogues of arylpropionic acids: synthesis, anti-inflammatory activity and ulcerogenic potential., 42 (2): [PMID:17052805] [10.1016/j.ejmech.2006.09.001] |
| 57. Fujikawa M, Nakao K, Shimizu R, Akamatsu M.. (2007) QSAR study on permeability of hydrophobic compounds with artificial membranes., 15 (11): [PMID:17418579] [10.1016/j.bmc.2007.03.040] |
| 58. Fang L, Zhang Y, Lehmann J, Wang Y, Ji H, Ding D.. (2007) Design and synthesis of furoxan-based nitric oxide-releasing glucocorticoid derivatives with potent anti-inflammatory activity and improved safety., 17 (4): [PMID:17129724] [10.1016/j.bmcl.2006.11.018] |
| 59. Ottaviani G, Martel S, Carrupt PA.. (2007) In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities., 50 (4): [PMID:17300161] [10.1021/jm0611105] |
| 60. Baert B, Deconinck E, Van Gele M, Slodicka M, Stoppie P, Bodé S, Slegers G, Vander Heyden Y, Lambert J, Beetens J, De Spiegeleer B.. (2007) Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds., 15 (22): [PMID:17827020] [10.1016/j.bmc.2007.07.050] |
| 61. Matsuda H, Ninomiya K, Morikawa T, Yasuda D, Yamaguchi I, Yoshikawa M.. (2008) Protective effects of amide constituents from the fruit of Piper chaba on D-galactosamine/TNF-alpha-induced cell death in mouse hepatocytes., 18 (6): [PMID:18289853] [10.1016/j.bmcl.2008.01.101] |
| 62. Cherkasov A, Ban F, Santos-Filho O, Thorsteinson N, Fallahi M, Hammond GL.. (2008) An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin., 51 (7): [PMID:18330978] [10.1021/jm7011485] |
| 63. Otsuka H, Hirai Y, Nagao T, Yamasaki K.. (1988) Anti-inflammatory activity of benzoxazinoids from roots of Coix lachryma-jobi var. ma-yuen., 51 (1): [PMID:2453615] [10.1021/np50055a009] |
| 64. Wan H, Ahman M, Holmén AG.. (2009) Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs., 52 (6): [PMID:19256501] [10.1021/jm801441s] |
| 65. Marco-Contelles J, León R, de los Ríos C, Samadi A, Bartolini M, Andrisano V, Huertas O, Barril X, Luque FJ, Rodríguez-Franco MI, López B, López MG, García AG, Carreiras Mdo C, Villarroya M.. (2009) Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's disease., 52 (9): [PMID:19374444] [10.1021/jm801292b] |
| 66. Ukiya M, Akihisa T, Yasukawa K, Tokuda H, Suzuki T, Kimura Y.. (2006) Anti-inflammatory, anti-tumor-promoting, and cytotoxic activities of constituents of marigold (Calendula officinalis) flowers., 69 (12): [PMID:17190444] [10.1021/np068016b] |
| 67. Prinsep MR, Thomson RA, West ML, Wylie BL.. (1996) Tolypodiol, an antiinflammatory diterpenoid from the cyanobacterium Tolypothrix nodosa., 59 (8): [PMID:8792625] [10.1021/np9602574] |
| 68. Pedersen JM, Matsson P, Bergström CA, Norinder U, Hoogstraate J, Artursson P.. (2008) Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2)., 51 (11): [PMID:18457386] [10.1021/jm7015683] |
| 69. Qiu L, Zhao F, Jiang ZH, Chen LX, Zhao Q, Liu HX, Yao XS, Qiu F.. (2008) Steroids and flavonoids from Physalis alkekengi var. franchetii and their inhibitory effects on nitric oxide production., 71 (4): [PMID:18348534] [10.1021/np700713r] |
| 70. Hutter JA, Salman M, Stavinoha WB, Satsangi N, Williams RF, Streeper RT, Weintraub ST.. (1996) Antiinflammatory C-glucosyl chromone from Aloe barbadensis., 59 (5): [PMID:8778246] [10.1021/np9601519] |
| 71. Yoshikawa M, Morikawa T, Kashima Y, Ninomiya K, Matsuda H.. (2003) Structures of new dammarane-type Triterpene Saponins from the flower buds of Panax notoginseng and hepatoprotective effects of principal Ginseng Saponins., 66 (7): [PMID:12880307] [10.1021/np030015l] |
| 72. Alimuddin M, Grant D, Bulloch D, Lee N, Peacock M, Dahl R.. (2008) Determination of log D via automated microfluidic liquid-liquid extraction., 51 (16): [PMID:18666772] [10.1021/jm8005228] |
| 73. Pérez-Garrido A, Morales Helguera A, Abellán Guillén A, Cordeiro MN, Garrido Escudero A.. (2009) Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins., 17 (2): [PMID:19056282] [10.1016/j.bmc.2008.11.040] |
| 74. Camps P, Formosa X, Galdeano C, Muñoz-Torrero D, Ramírez L, Gómez E, Isambert N, Lavilla R, Badia A, Clos MV, Bartolini M, Mancini F, Andrisano V, Arce MP, Rodríguez-Franco MI, Huertas O, Dafni T, Luque FJ.. (2009) Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds., 52 (17): [PMID:19663388] [10.1021/jm900859q] |
| 75. Lee PH, Conradi R, Shanmugasundaram V.. (2010) Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay., 20 (1): [PMID:19963379] [10.1016/j.bmcl.2009.11.039] |
| 76. Du-Cuny L, Song Z, Moses S, Powis G, Mash EA, Meuillet EJ, Zhang S.. (2009) Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain., 17 (19): [PMID:19734051] [10.1016/j.bmc.2009.08.022] |
| 77. Matsuda H, Ninomiya K, Morikawa T, Yasuda D, Yamaguchi I, Yoshikawa M.. (2009) Hepatoprotective amide constituents from the fruit of Piper chaba: Structural requirements, mode of action, and new amides., 17 (20): [PMID:19775895] [10.1016/j.bmc.2009.08.050] |
| 78. Morikawa T, Pan Y, Ninomiya K, Imura K, Matsuda H, Yoshikawa M, Yuan D, Muraoka O.. (2010) Acylated phenylethanoid oligoglycosides with hepatoprotective activity from the desert plant Cistanche tubulosa., 18 (5): [PMID:20159656] [10.1016/j.bmc.2010.01.047] |
| 79. Arce MP, Rodríguez-Franco MI, González-Muñoz GC, Pérez C, López B, Villarroya M, López MG, García AG, Conde S.. (2009) Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease., 52 (22): [PMID:19856923] [10.1021/jm900628z] |
| 80. Jiao WH, Gao H, Li CY, Zhao F, Jiang RW, Wang Y, Zhou GX, Yao XS.. (2010) Quassidines A-D, bis-beta-carboline alkaloids from the stems of Picrasma quassioides., 73 (2): [PMID:20095629] [10.1021/np900538r] |
| 81. Bellavance E, Luu-The V, Poirier D.. (2009) Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone., 52 (23): [PMID:19772289] [10.1021/jm900921c] |
| 82. Sui X, Sun J, Li H, Wang Y, Liu J, Liu X, Zhang W, Chen L, He Z.. (2009) Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data., 44 (11): [PMID:19586686] [10.1016/j.ejmech.2009.06.004] |
| 83. Diamandis P, Wildenhain J, Clarke ID, Sacher AG, Graham J, Bellows DS, Ling EK, Ward RJ, Jamieson LG, Tyers M, Dirks PB.. (2007) Chemical genetics reveals a complex functional ground state of neural stem cells., 3 (5): [PMID:17417631] [10.1038/nchembio873] |
| 84. Yuan J, Johnson RL, Huang R, Wichterman J, Jiang H, Hayton K, Fidock DA, Wellems TE, Inglese J, Austin CP, Su XZ.. (2009) Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum., 5 (10): [PMID:19734910] [10.1038/nchembio.215] |
| 85. Li J, Zhao F, Li MZ, Chen LX, Qiu F.. (2010) Diarylheptanoids from the Rhizomes of Curcuma kwangsiensis., 73 (10): [PMID:20879743] [10.1021/np100392m] |
| 86. PubChem BioAssay data set, |
| 87. PubChem BioAssay data set, |
| 88. Obach RS, Lombardo F, Waters NJ.. (2008) Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds., 36 (7): [PMID:18426954] [10.1124/dmd.108.020479] |
| 89. Talevi A, Goodarzi M, Ortiz EV, Duchowicz PR, Bellera CL, Pesce G, Castro EA, Bruno-Blanch LE.. (2011) Prediction of drug intestinal absorption by new linear and non-linear QSPR., 46 (1): [PMID:21112128] [10.1016/j.ejmech.2010.11.005] |
| 90. Ekins S, Williams AJ, Xu JJ.. (2010) A predictive ligand-based Bayesian model for human drug-induced liver injury., 38 (12): [PMID:20843939] [10.1124/dmd.110.035113] |
| 91. Fourches D, Barnes JC, Day NC, Bradley P, Reed JZ, Tropsha A.. (2010) Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species., 23 (1): [PMID:20014752] [10.1021/tx900326k] |
| 92. Unpublished dataset, |
| 93. PubChem BioAssay data set, |
| 94. PubChem BioAssay data set, |
| 95. PubChem BioAssay data set, |
| 96. Honda T, Yoshizawa H, Sundararajan C, David E, Lajoie MJ, Favaloro FG, Janosik T, Su X, Honda Y, Roebuck BD, Gribble GW.. (2011) Tricyclic compounds containing nonenolizable cyano enones. A novel class of highly potent anti-inflammatory and cytoprotective agents., 54 (6): [PMID:21361338] [10.1021/jm101445p] |
| 97. Gozalbes R, Jacewicz M, Annand R, Tsaioun K, Pineda-Lucena A.. (2011) QSAR-based permeability model for drug-like compounds., 19 (8): [PMID:21458999] [10.1016/j.bmc.2011.03.011] |
| 98. Zeng N, Shen Y, Li LZ, Jiao WH, Gao PY, Song SJ, Chen WS, Lin HW.. (2011) Anti-inflammatory triterpenes from the leaves of Rosa laevigata., 74 (4): [PMID:21384845] [10.1021/np1007922] |
| 99. Van Cleemput M, Cattoor K, De Bosscher K, Haegeman G, De Keukeleire D, Heyerick A.. (2009) Hop (Humulus lupulus)-derived bitter acids as multipotent bioactive compounds., 72 (6): [PMID:19476340] [10.1021/np800740m] |
| 100. Li J, Liao CR, Wei JQ, Chen LX, Zhao F, Qiu F.. (2011) Diarylheptanoids from Curcuma kwangsiensis and their inhibitory activity on nitric oxide production in lipopolysaccharide-activated macrophages., 21 (18): [PMID:21807513] [10.1016/j.bmcl.2011.07.012] |
| 101. Tang H, Zhao LZ, Zhao HT, Huang SL, Zhong SM, Qin JK, Chen ZF, Huang ZS, Liang H.. (2011) Hybrids of oxoisoaporphine-tacrine congeners: novel acetylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation inhibitors., 46 (10): [PMID:21871694] [10.1016/j.ejmech.2011.08.002] |
| 102. PubChem BioAssay data set, |
| 103. Tukey RH, Strassburg CP.. (2000) Human UDP-glucuronosyltransferases: metabolism, expression, and disease., 40 (1): [PMID:10836148] [10.1146/annurev.pharmtox.40.1.581] |
| 104. Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program. DrugMatrix in vitro pharmacology data, |
| 105. Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W.. (2011) Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps)., 7 (12): [PMID:22194678] [10.1371/journal.pcbi.1002310] |
| 106. Redondo M, Zarruk JG, Ceballos P, Pérez DI, Pérez C, Perez-Castillo A, Moro MA, Brea J, Val C, Cadavid MI, Loza MI, Campillo NE, Martínez A, Gil C.. (2012) Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model., 47 [PMID:22100138] [10.1016/j.ejmech.2011.10.040] |
| 107. Chiriano G, De Simone A, Mancini F, Perez DI, Cavalli A, Bolognesi ML, Legname G, Martinez A, Andrisano V, Carloni P, Roberti M.. (2012) A small chemical library of 2-aminoimidazole derivatives as BACE-1 inhibitors: Structure-based design, synthesis, and biological evaluation., 48 [PMID:22209418] [10.1016/j.ejmech.2011.12.016] |
| 108. González-Muñoz GC, Arce MP, López B, Pérez C, Romero A, del Barrio L, Martín-de-Saavedra MD, Egea J, León R, Villarroya M, López MG, García AG, Conde S, Rodríguez-Franco MI.. (2011) N-acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease., 46 (6): [PMID:21420206] [10.1016/j.ejmech.2011.03.003] |
| 109. Tang H, Zhao HT, Zhong SM, Wang ZY, Chen ZF, Liang H.. (2012) Novel oxoisoaporphine-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation., 22 (6): [PMID:22341944] [10.1016/j.bmcl.2012.01.090] |
| 110. PubChem BioAssay data set, |
| 111. Palomo V, Perez DI, Perez C, Morales-Garcia JA, Soteras I, Alonso-Gil S, Encinas A, Castro A, Campillo NE, Perez-Castillo A, Gil C, Martinez A.. (2012) 5-imino-1,2,4-thiadiazoles: first small molecules as substrate competitive inhibitors of glycogen synthase kinase 3., 55 (4): [PMID:22257026] [10.1021/jm201463v] |
| 112. Akula N, Midzak A, Lecanu L, Papadopoulos V.. (2012) Identification of small-molecule inhibitors of the steroidogenic acute regulatory protein (STARD1) by structure-based design., 22 (12): [PMID:22575868] [10.1016/j.bmcl.2012.04.058] |
| 113. Zhang F, Wu ZJ, Sun LN, Wang J, Tao X, Chen WS.. (2012) Iridoid glucosides and a C₁₃-norisoprenoid from Lamiophlomis rotata and their effects on NF-κB activation., 22 (13): [PMID:22664131] [10.1016/j.bmcl.2012.04.087] |
| 114. Schwab D, Fischer H, Tabatabaei A, Poli S, Huwyler J.. (2003) Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery., 46 (9): [PMID:12699389] [10.1021/jm021012t] |
| 115. Bossuyt X, Müller M, Hagenbuch B, Meier PJ.. (1996) Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver., 276 (1): [PMID:8786566] |
| 116. Yates CR, Chang C, Kearbey JD, Yasuda K, Schuetz EG, Miller DD, Dalton JT, Swaan PW.. (2003) Structural determinants of P-glycoprotein-mediated transport of glucocorticoids., 20 (1): [PMID:14661924] [10.1023/b:pham.0000003377.39548.f6] |
| 117. Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioka N, Komano T, Hori R.. (1992) Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone., 267 (1): [PMID:1360010] [10.1016/s0021-9258(18)35757-0] |
| 118. Orlowski S, Mir LM, Belehradek J, Garrigos M.. (1996) Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators., 317 (1): [PMID:8713080] [10.1042/bj3170515] |
| 119. Karssen AM, Meijer OC, van der Sandt IC, Lucassen PJ, de Lange EC, de Boer AG, de Kloet ER.. (2001) Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain., 142 (1): [PMID:11356720] [10.1210/en.142.6.2686] |
| 120. Uhr M, Holsboer F, Müller MB.. (2002) Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins., 14 (1): [PMID:12213137] [10.1046/j.1365-2826.2002.00836.x] |
| 121. Kim RB, Wandel C, Leake B, Cvetkovic M, Fromm MF, Dempsey PJ, Roden MM, Belas F, Chaudhary AK, Roden DM, Wood AJ, Wilkinson GR.. (1999) Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein., 16 (1): [PMID:10213372] [10.1023/a:1018877803319] |
| 122. Imai Y, Asada S, Tsukahara S, Ishikawa E, Tsuruo T, Sugimoto Y.. (2003) Breast cancer resistance protein exports sulfated estrogens but not free estrogens., 64 (1): [PMID:12920197] [10.1124/mol.64.3.610] |
| 123. Kanai N, Lu R, Bao Y, Wolkoff AW, Schuster VL.. (1996) Transient expression of oatp organic anion transporter in mammalian cells: identification of candidate substrates., 270 (1): [PMID:8779893] [10.1152/ajprenal.1996.270.2.f319] |
| 124. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
| 125. Baumgartner L, Sosa S, Atanasov AG, Bodensieck A, Fakhrudin N, Bauer J, Favero GD, Ponti C, Heiss EH, Schwaiger S, Ladurner A, Widowitz U, Loggia RD, Rollinger JM, Werz O, Bauer R, Dirsch VM, Tubaro A, Stuppner H.. (2011) Lignan derivatives from Krameria lappacea roots inhibit acute inflammation in vivo and pro-inflammatory mediators in vitro., 74 (8): [PMID:21800856] [10.1021/np200343t] |
| 126. Chavarría C, Perez DI, Pérez C, Morales Garcia JA, Alonso-Gil S, Pérez-Castillo A, Gil C, Souza JM, Porcal W.. (2012) Microwave-assisted synthesis of hydroxyphenyl nitrones with protective action against oxidative stress., 58 [PMID:23085773] [10.1016/j.ejmech.2012.09.044] |
| 127. Ding L, Zhao F, Chen L, Jiang Z, Liu Y, Li Z, Qiu F, Yao X.. (2012) New monoterpene glycosides from Paeonia suffruticosa Andrews and their inhibition on NO production in LPS-induced RAW 264.7 cells., 22 (23): [PMID:23067550] [10.1016/j.bmcl.2012.09.034] |
| 128. Akamatsu M.. (2011) Importance of physicochemical properties for the design of new pesticides., 59 (7): [PMID:20879794] [10.1021/jf102525e] |
| 129. Peng K, Yang L, Zhao S, Chen L, Zhao F, Qiu F.. (2013) Chemical constituents from the fruit of Gardenia jasminoides and their inhibitory effects on nitric oxide production., 23 (4): [PMID:23305920] [10.1016/j.bmcl.2012.11.099] |
| 130. Wang SJ, Bao L, Han JJ, Wang QX, Yang XL, Wen HA, Guo LD, Li SJ, Zhao F, Liu HW.. (2013) Pleurospiroketals A-E, perhydrobenzannulated 5,5-spiroketal sesquiterpenes from the edible mushroom Pleurotus cornucopiae., 76 (1): [PMID:23294419] [10.1021/np3006524] |
| 131. Liu Y, Ma J, Zhao Q, Liao C, Ding L, Chen L, Zhao F, Qiu F.. (2013) Guaiane-type sesquiterpenes from Curcuma phaeocaulis and their inhibitory effects on nitric oxide production., 76 (6): [PMID:23755850] [10.1021/np400202f] |
| 132. Ning X, Guo Y, Ma X, Zhu R, Tian C, Zhang Z, Wang X, Ma Z, Liu J.. (2013) Design, synthesis and pharmacological evaluation of (E)-3,4-dihydroxy styryl sulfonamides derivatives as multifunctional neuroprotective agents against oxidative and inflammatory injury., 21 (17): [PMID:23870700] [10.1016/j.bmc.2013.05.043] |
| 133. De Bruyn T, van Westen GJ, Ijzerman AP, Stieger B, de Witte P, Augustijns PF, Annaert PP.. (2013) Structure-based identification of OATP1B1/3 inhibitors., 83 (6): [PMID:23571415] [10.1124/mol.112.084152] |
| 134. Sun Y, Chen J, Chen X, Huang L, Li X.. (2013) Inhibition of cholinesterase and monoamine oxidase-B activity by Tacrine-Homoisoflavonoid hybrids., 21 (23): [PMID:24128814] [10.1016/j.bmc.2013.09.050] |
| 135. Di Pietro O, Viayna E, Vicente-García E, Bartolini M, Ramón R, Juárez-Jiménez J, Clos MV, Pérez B, Andrisano V, Luque FJ, Lavilla R, Muñoz-Torrero D.. (2014) 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies., 73 [PMID:24389509] [10.1016/j.ejmech.2013.12.008] |
| 136. Biour M, Ben Salem C, Chazouillères O, Grangé JD, Serfaty L, Poupon R.. (2004) [Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs]., 28 (8-9): [PMID:15646539] [10.1016/s0399-8320(04)95062-2] |
| 137. PubChem BioAssay data set, |
| 138. PubChem BioAssay data set, |
| 139. Liu ZG, Li ZL, Bai J, Meng DL, Li N, Pei YH, Zhao F, Hua HM.. (2014) Anti-inflammatory diterpenoids from the roots of Euphorbia ebracteolata., 77 (4): [PMID:24660966] [10.1021/np400873v] |
| 140. Salado IG, Redondo M, Bello ML, Perez C, Liachko NF, Kraemer BC, Miguel L, Lecourtois M, Gil C, Martinez A, Perez DI.. (2014) Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis., 57 (6): [PMID:24592867] [10.1021/jm500065f] |
| 141. Dunwell DW, Evans D.. (1977) Synthesis and antiinflammatory activity of some 2-aryl-6-benzoxazoleacetic acid derivatives., 20 (6): [PMID:874954] [10.1021/jm00216a011] |
| 142. Justice JB.. (1978) A Fujita--Ban structure--activity analysis of 44 steroids., 21 (5): [PMID:660591] [10.1021/jm00203a011] |
| 143. Hicks TA, Smith CE, Williamson WR, Day EH.. (1979) Potential antiinflammatory compounds. 1. Antiinflammatory phenylpiperidine derivatives., 22 (12): [PMID:536991] [10.1021/jm00198a006] |
| 144. Smith CE, Williamson WR, Cashin CH, Kitchen EA.. (1979) Potential antiinflammatory compounds. 3. Compounds derived from acenaphthene and indan., 22 (12): [PMID:536992] [10.1021/jm00198a007] |
| 145. Ning X, Guo Y, Wang X, Ma X, Tian C, Shi X, Zhu R, Cheng C, Du Y, Ma Z, Zhang Z, Liu J.. (2014) Design, synthesis, and biological evaluation of (e)-3,4-dihydroxystyryl aralkyl sulfones and sulfoxides as novel multifunctional neuroprotective agents., 57 (10): [PMID:24697335] [10.1021/jm500258v] |
| 146. El Masry AH, Braun VC, Nielsen CJ, Pratt WB.. (1977) Synthesis and biological action of two glucocorticoid alkylating agents., 20 (9): [PMID:926113] [10.1021/jm00219a005] |
| 147. Lee DL, Kollman PA, Marsh FJ, Wolff ME.. (1977) Quantitative relationships between steroid structure and binding to putative progesterone receptors., 20 (9): [PMID:926114] [10.1021/jm00219a006] |
| 148. Evans D, Smith CE, Williamson WR.. (1977) Synthesis and antiinflammatory activity of some 2-substituted 4- and 7-benzoxazoleacetic and alpha-methylacetic acids., 20 (1): [PMID:833819] [10.1021/jm00211a039] |
| 149. Goudie AC, Gaster LM, Lake AW, Rose CJ, Freeman PC, Hughes BO, Miller D.. (1978) 4-(6-Methoxy-2-naphthyl)butan-2-one and related analogues, a novel structural class of antiinflammatory compounds., 21 (12): [PMID:722734] [10.1021/jm00210a016] |
| 150. Sola I, Artigas A, Taylor MC, Gbedema SY, Pérez B, Clos MV, Wright CW, Kelly JM, Muñoz-Torrero D.. (2014) Synthesis and antiprotozoal activity of oligomethylene- and p-phenylene-bis(methylene)-linked bis(+)-huprines., 24 (23): [PMID:25454267] [10.1016/j.bmcl.2014.10.025] |
| 151. Ma K, Ren J, Han J, Bao L, Li L, Yao Y, Sun C, Zhou B, Liu H.. (2014) Ganoboninketals A-C, Antiplasmodial 3,4-seco-27-Norlanostane Triterpenes from Ganoderma boninense Pat., 77 (8): [PMID:25076059] [10.1021/np5002863] |
| 152. Yin GP, Li LC, Zhang QZ, An YW, Zhu JJ, Wang ZM, Chou GX, Wang ZT.. (2014) iNOS inhibitory activity of sesquiterpenoids and a monoterpenoid from the rhizomes of Curcuma wenyujin., 77 (10): [PMID:25275213] [10.1021/np400984c] |
| 153. Pérez-Areales FJ, Di Pietro O, Espargaró A, Vallverdú-Queralt A, Galdeano C, Ragusa IM, Viayna E, Guillou C, Clos MV, Pérez B, Sabaté R, Lamuela-Raventós RM, Luque FJ, Muñoz-Torrero D.. (2014) Shogaol-huprine hybrids: dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties., 22 (19): [PMID:25156301] [10.1016/j.bmc.2014.07.053] |
| 154. Huang L, Miao H, Sun Y, Meng F, Li X.. (2014) Discovery of indanone derivatives as multi-target-directed ligands against Alzheimer's disease., 87 [PMID:25282266] [10.1016/j.ejmech.2014.09.081] |
| 155. Lan JS, Xie SS, Li SY, Pan LF, Wang XB, Kong LY.. (2014) Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease., 22 (21): [PMID:25282654] [10.1016/j.bmc.2014.08.035] |
| 156. Dong J, Shao W, Yan P, Cai X, Fang L, Zhao X, Lin W, Cai Y.. (2015) Curcumolide, a unique sesquiterpenoid with anti-inflammatory properties from Curcuma wenyujin., 25 (2): [PMID:25515561] [10.1016/j.bmcl.2014.11.075] |
| 157. Xi FM, Li CT, Han J, Yu SS, Wu ZJ, Chen WS.. (2014) Thiophenes, polyacetylenes and terpenes from the aerial parts of Eclipata prostrate., 22 (22): [PMID:25443644] [10.1016/j.bmc.2014.06.051] |
| 158. Zhang F, Zhang CR, Tao X, Wang J, Chen WS, Yue JM.. (2014) Phragmalin-type limonoids with NF-κB inhibition from Chukrasia tabularis var. velutina., 24 (16): [PMID:25037915] [10.1016/j.bmcl.2014.06.069] |
| 159. Di Pietro O, Pérez-Areales FJ, Juárez-Jiménez J, Espargaró A, Clos MV, Pérez B, Lavilla R, Sabaté R, Luque FJ, Muñoz-Torrero D.. (2014) Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies., 84 [PMID:25016233] [10.1016/j.ejmech.2014.07.021] |
| 160. Huang M, Xie SS, Jiang N, Lan JS, Kong LY, Wang XB.. (2015) Multifunctional coumarin derivatives: monoamine oxidase B (MAO-B) inhibition, anti-β-amyloid (Aβ) aggregation and metal chelation properties against Alzheimer's disease., 25 (3): [PMID:25542589] [10.1016/j.bmcl.2014.12.034] |
| 161. Xie SS, Lan JS, Wang XB, Jiang N, Dong G, Li ZR, Wang KD, Guo PP, Kong LY.. (2015) Multifunctional tacrine-trolox hybrids for the treatment of Alzheimer's disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties., 93 [PMID:25656088] [10.1016/j.ejmech.2015.01.058] |
| 162. Xie SS, Wang X, Jiang N, Yu W, Wang KD, Lan JS, Li ZR, Kong LY.. (2015) Multi-target tacrine-coumarin hybrids: cholinesterase and monoamine oxidase B inhibition properties against Alzheimer's disease., 95 [PMID:25812965] [10.1016/j.ejmech.2015.03.040] |
| 163. Ren S, Zeng J, Mei Y, Zhang JZ, Yan SF, Fei J, Chen L.. (2013) Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors., 41 (1): [PMID:23033255] [10.1124/dmd.112.048264] |
| 164. Farrell TL, Poquet L, Dew TP, Barber S, Williamson G.. (2012) Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study., 40 (2): [PMID:22096083] [10.1124/dmd.111.041665] |
| 165. PubChem BioAssay data set, |
| 166. Cahlíková L, Pérez DI, Štěpánková Š, Chlebek J, Šafratová M, Hošt'álková A, Opletal L.. (2015) In Vitro Inhibitory Effects of 8-O-Demethylmaritidine and Undulatine on Acetylcholinesterase and Their Predicted Penetration across the Blood-Brain Barrier., 78 (6): [PMID:26030662] [10.1021/acs.jnatprod.5b00191] |
| 167. Hyldgaard MG, Purup S, Bond AD, Fretté XC, Qu H, Jensen KT, Christensen LP.. (2015) Guaianolides and a seco-Eudesmane from the Resinous Exudates of Cushion Bush (Leucophyta brownii) and Evaluation of Their Cytostatic and Anti-inflammatory Activity., 78 (8): [PMID:26218649] [10.1021/acs.jnatprod.5b00208] |
| 168. Wang Z, Wang Y, Wang B, Li W, Huang L, Li X.. (2015) Design, Synthesis, and Evaluation of Orally Available Clioquinol-Moracin M Hybrids as Multitarget-Directed Ligands for Cognitive Improvement in a Rat Model of Neurodegeneration in Alzheimer's Disease., 58 (21): [PMID:26473791] [10.1021/acs.jmedchem.5b01222] |
| 169. Di Pietro O, Vicente-García E, Taylor MC, Berenguer D, Viayna E, Lanzoni A, Sola I, Sayago H, Riera C, Fisa R, Clos MV, Pérez B, Kelly JM, Lavilla R, Muñoz-Torrero D.. (2015) Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity., 105 [PMID:26479031] [10.1016/j.ejmech.2015.10.007] |
| 170. Liu ZG, Li ZL, Li DH, Li N, Bai J, Zhao F, Meng DL, Hua HM.. (2016) ent-Abietane-type diterpenoids from the roots of Euphorbia ebracteolata with their inhibitory activities on LPS-induced NO production in RAW 264.7 macrophages., 26 (1): [PMID:26615888] [10.1016/j.bmcl.2015.11.080] |
| 171. Rathore B, Chandra Sekhar Jaggarapu MM, Ganguly A, Reddy Rachamalla HK, Banerjee R.. (2016) Cationic lipid-conjugated hydrocortisone as selective antitumor agent., 108 [PMID:26695732] [10.1016/j.ejmech.2015.11.033] |
| 172. Xie SS, Lan JS, Wang X, Wang ZM, Jiang N, Li F, Wu JJ, Wang J, Kong LY.. (2016) Design, synthesis and biological evaluation of novel donepezil-coumarin hybrids as multi-target agents for the treatment of Alzheimer's disease., 24 (7): [PMID:26917219] [10.1016/j.bmc.2016.02.023] |
| 173. Pan W, Hu K, Bai P, Yu L, Ma Q, Li T, Zhang X, Chen C, Peng K, Liu W, Sang Z.. (2016) Design, synthesis and evaluation of novel ferulic acid-memoquin hybrids as potential multifunctional agents for the treatment of Alzheimer's disease., 26 (10): [PMID:27072909] [10.1016/j.bmcl.2016.03.086] |
| 174. Wang M, Wang F, Xu F, Ding LQ, Zhang Q, Li HX, Zhao F, Wang LQ, Zhu LH, Chen LX, Qiu F.. (2016) Two pairs of farnesyl phenolic enantiomers as natural nitric oxide inhibitors from Ganoderma sinense., 26 (14): [PMID:27256914] [10.1016/j.bmcl.2016.05.037] |
| 175. Xu W, Wang X, Wang Z, Wu J, Li F, Wang J, Kong L. (2016) Synthesis and evaluation of donepezilferulic acid hybrids as multi-target-directed ligands against Alzheimer's disease, 7 (5): [10.1039/C6MD00053C] |
| 176. Hroch L, Benek O, Guest P, Aitken L, Soukup O, Janockova J, Musil K, Dohnal V, Dolezal R, Kuca K, Smith TK, Gunn-Moore F, Musilek K.. (2016) Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer's disease treatment., 26 (15): [PMID:27287370] [10.1016/j.bmcl.2016.05.087] |
| 177. Wang J, Wang ZM, Li XM, Li F, Wu JJ, Kong LY, Wang XB.. (2016) Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer's disease based on the fusion of donepezil and melatonin., 24 (18): [PMID:27460699] [10.1016/j.bmc.2016.07.025] |
| 178. WHO Anatomical Therapeutic Chemical Classification, |
| 179. British National Formulary (72nd edition), |
| 180. Ryabtsova O, Joossens J, Van Der Veken P, Vanden Berghe W, Augustyns K, De Winter H.. (2016) Novel selective glucocorticoid receptor agonists (SEGRAs) with a covalent warhead for long-lasting inhibition., 26 (20): [PMID:27612544] [10.1016/j.bmcl.2016.08.091] |
| 181. Sola I, Artigas A, Taylor MC, Pérez-Areales FJ, Viayna E, Clos MV, Pérez B, Wright CW, Kelly JM, Muñoz-Torrero D.. (2016) Synthesis and biological evaluation of N-cyanoalkyl-, N-aminoalkyl-, and N-guanidinoalkyl-substituted 4-aminoquinoline derivatives as potent, selective, brain permeable antitrypanosomal agents., 24 (21): [PMID:27591008] [10.1016/j.bmc.2016.08.036] |
| 182. Sun CP, Qiu CY, Yuan T, Nie XF, Sun HX, Zhang Q, Li HX, Ding LQ, Zhao F, Chen LX, Qiu F.. (2016) Antiproliferative and Anti-inflammatory Withanolides from Physalis angulata., 79 (6): [PMID:27295506] [10.1021/acs.jnatprod.6b00094] |
| 183. Wang Z, Wu J, Yang X, Cai P, Liu Q, Wang KDG, Kong L, Wang X.. (2016) Neuroprotective effects of benzyloxy substituted small molecule monoamine oxidase B inhibitors in Parkinson's disease., 24 (22): [PMID:27692996] [10.1016/j.bmc.2016.09.050] |
| 184. Zhao JJ, Guo YQ, Yang DP, Xue X, Liu Q, Zhu LP, Yin S, Zhao ZM.. (2016) Chlojaponilactone B from Chloranthus japonicus: Suppression of Inflammatory Responses via Inhibition of the NF-κB Signaling Pathway., 79 (9): [PMID:27588583] [10.1021/acs.jnatprod.6b00355] |
| 185. Wang ZM, Cai P, Liu QH, Xu DQ, Yang XL, Wu JJ, Kong LY, Wang XB.. (2016) Rational modification of donepezil as multifunctional acetylcholinesterase inhibitors for the treatment of Alzheimer's disease., 123 [PMID:27484514] [10.1016/j.ejmech.2016.07.052] |
| 186. Panek D, Więckowska A, Wichur T, Bajda M, Godyń J, Jończyk J, Mika K, Janockova J, Soukup O, Knez D, Korabecny J, Gobec S, Malawska B.. (2017) Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives with alicyclic amines targeting cholinesterases, beta-secretase and amyloid beta aggregation., 125 [PMID:27721153] [10.1016/j.ejmech.2016.09.078] |
| 187. DrugMatrix, [10.6019/CHEMBL3885881] |
| 188. Martín-Martínez M, Pérez-Gordillo FL, Álvarez de la Rosa D, Rodríguez Y, Gerona-Navarro G, González-Muñiz R, Zhou MM.. (2017) Modulating Mineralocorticoid Receptor with Non-steroidal Antagonists. New Opportunities for the Development of Potent and Selective Ligands without Off-Target Side Effects., 60 (7): [PMID:28051871] [10.1021/acs.jmedchem.6b01065] |
| 189. Soeberdt M, Molenveld P, Storcken RP, Bouzanne des Mazery R, Sterk GJ, Autar R, Bolster MG, Wagner C, Aerts SN, van Holst FR, Wegert A, Tangherlini G, Frehland B, Schepmann D, Metze D, Lotts T, Knie U, Lin KY, Huang TY, Lai CC, Ständer S, Wünsch B, Abels C.. (2017) Design and Synthesis of Enantiomerically Pure Decahydroquinoxalines as Potent and Selective κ-Opioid Receptor Agonists with Anti-Inflammatory Activity in Vivo., 60 (6): [PMID:28218838] [10.1021/acs.jmedchem.6b01868] |
| 190. Warner DJ, Chen H, Cantin LD, Kenna JG, Stahl S, Walker CL, Noeske T.. (2012) Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification., 40 (12): [PMID:22961681] [10.1124/dmd.112.047068] |
| 191. Joshi MC, Okombo J, Nsumiwa S, Ndove J, Taylor D, Wiesner L, Hunter R, Chibale K, Egan TJ.. (2017) 4-Aminoquinoline Antimalarials Containing a Benzylmethylpyridylmethylamine Group Are Active against Drug Resistant Plasmodium falciparum and Exhibit Oral Activity in Mice., 60 (24): [PMID:29185748] [10.1021/acs.jmedchem.7b01537] |
| 192. Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W.. (2016) DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans., 21 (4): [PMID:26948801] [10.1016/j.drudis.2016.02.015] |
| 193. Lan JS, Zhang T, Liu Y, Yang J, Xie SS, Liu J, Miao ZY, Ding Y.. (2017) Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors., 133 [PMID:28388521] [10.1016/j.ejmech.2017.02.045] |
| 194. Xia CL, Wang N, Guo QL, Liu ZQ, Wu JQ, Huang SL, Ou TM, Tan JH, Wang HG, Li D, Huang ZS.. (2017) Design, synthesis and evaluation of 2-arylethenyl-N-methylquinolinium derivatives as effective multifunctional agents for Alzheimer's disease treatment., 130 [PMID:28242549] [10.1016/j.ejmech.2017.02.042] |
| 195. Monjas L, Arce MP, León R, Egea J, Pérez C, Villarroya M, López MG, Gil C, Conde S, Rodríguez-Franco MI.. (2017) Enzymatic and solid-phase synthesis of new donepezil-based L- and d-glutamic acid derivatives and their pharmacological evaluation in models related to Alzheimer's disease and cerebral ischemia., 130 [PMID:28242552] [10.1016/j.ejmech.2017.02.034] |
| 196. Yan G, Hao L, Niu Y, Huang W, Wang W, Xu F, Liang L, Wang C, Jin H, Xu P.. (2017) 2-Substituted-thio-N-(4-substituted-thiazol/1H-imidazol-2-yl)acetamides as BACE1 inhibitors: Synthesis, biological evaluation and docking studies., 137 [PMID:28624701] [10.1016/j.ejmech.2017.06.020] |
| 197. Wang Z, Hu J, Yang X, Feng X, Li X, Huang L, Chan ASC.. (2018) Design, Synthesis, and Evaluation of Orally Bioavailable Quinoline-Indole Derivatives as Innovative Multitarget-Directed Ligands: Promotion of Cell Proliferation in the Adult Murine Hippocampus for the Treatment of Alzheimer's Disease., 61 (5): [PMID:29420891] [10.1021/acs.jmedchem.7b01417] |
| 198. Liu W, Wang H, Li X, Xu Y, Zhang J, Wang W, Gong Q, Qiu X, Zhu J, Mao F, Zhang H, Li J.. (2018) Design, synthesis and evaluation of vilazodone-tacrine hybrids as multitarget-directed ligands against depression with cognitive impairment., 26 (12): [PMID:29729987] [10.1016/j.bmc.2018.04.037] |
| 199. De Simone A, Bartolini M, Baschieri A, Apperley KYP, Chen HH, Guardigni M, Montanari S, Kobrlova T, Soukup O, Valgimigli L, Andrisano V, Keillor JW, Basso M, Milelli A.. (2017) Hydroxy-substituted trans-cinnamoyl derivatives as multifunctional tools in the context of Alzheimer's disease., 139 [PMID:28810189] [10.1016/j.ejmech.2017.07.058] |
| 200. Xu YX, Wang H, Li XK, Dong SN, Liu WW, Gong Q, Wang TD, Tang Y, Zhu J, Li J, Zhang HY, Mao F.. (2018) Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease., 143 [PMID:29172081] [10.1016/j.ejmech.2017.08.025] |
| 201. Yang HL, Cai P, Liu QH, Yang XL, Fang SQ, Tang YW, Wang C, Wang XB, Kong LY.. (2017) Design, synthesis, and evaluation of salicyladimine derivatives as multitarget-directed ligands against Alzheimer's disease., 25 (21): [PMID:28988627] [10.1016/j.bmc.2017.08.048] |
| 202. Salado IG, Zaldivar-Diez J, Sebastián-Pérez V, Li L, Geiger L, González S, Campillo NE, Gil C, Morales AV, Perez DI, Martinez A.. (2017) Leucine rich repeat kinase 2 (LRRK2) inhibitors based on indolinone scaffold: Potential pro-neurogenic agents., 138 [PMID:28688273] [10.1016/j.ejmech.2017.06.060] |
| 203. Yang HL, Cai P, Liu QH, Yang XL, Li F, Wang J, Wu JJ, Wang XB, Kong LY.. (2017) Design, synthesis and evaluation of coumarin-pargyline hybrids as novel dual inhibitors of monoamine oxidases and amyloid-β aggregation for the treatment of Alzheimer's disease., 138 [PMID:28728104] [10.1016/j.ejmech.2017.07.008] |
| 204. Lan JS, Ding Y, Liu Y, Kang P, Hou JW, Zhang XY, Xie SS, Zhang T.. (2017) Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease., 139 [PMID:28797883] [10.1016/j.ejmech.2017.07.055] |
| 205. Wang J, Cai P, Yang XL, Li F, Wu JJ, Kong LY, Wang XB.. (2017) Novel cinnamamide-dibenzylamine hybrids: Potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease., 139 [PMID:28800459] [10.1016/j.ejmech.2017.07.077] |
| 206. Hepnarova V, Korabecny J, Matouskova L, Jost P, Muckova L, Hrabinova M, Vykoukalova N, Kerhartova M, Kucera T, Dolezal R, Nepovimova E, Spilovska K, Mezeiova E, Pham NL, Jun D, Staud F, Kaping D, Kuca K, Soukup O.. (2018) The concept of hybrid molecules of tacrine and benzyl quinolone carboxylic acid (BQCA) as multifunctional agents for Alzheimer's disease., 150 [PMID:29533874] [10.1016/j.ejmech.2018.02.083] |
| 207. Yang X, Cai P, Liu Q, Wu J, Yin Y, Wang X, Kong L.. (2018) Novel 8-hydroxyquinoline derivatives targeting β-amyloid aggregation, metal chelation and oxidative stress against Alzheimer's disease., 26 (12): [PMID:29729985] [10.1016/j.bmc.2018.04.043] |
| 208. Chierrito TPC, Pedersoli-Mantoani S, Roca C, Sebastian-Pérez V, Martínez-Gonzalez L, Pérez DI, Perez C, Canales A, Cañada FJ, Campillo NE, Carvalho I, Martinez A.. (2018) Chameleon-like behavior of indolylpiperidines in complex with cholinesterases targets: Potent butyrylcholinesterase inhibitors., 145 [PMID:29335209] [10.1016/j.ejmech.2018.01.007] |
| 209. Nath C, Badavath VN, Thakur A, Ucar G, Acevedo O, Mohd Siddique MU, Jayaprakash V.. (2018) Curcumin-based pyrazoline analogues as selective inhibitors of human monoamine oxidase A., 9 (7): [PMID:30109004] [10.1039/C8MD00196K] |
| 210. Reis J, Cagide F, Valencia ME, Teixeira J, Bagetta D, Pérez C, Uriarte E, Oliveira PJ, Ortuso F, Alcaro S, Rodríguez-Franco MI, Borges F.. (2018) Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors., 158 [PMID:30245401] [10.1016/j.ejmech.2018.07.056] |
| 211. Unpublished dataset, |
| 212. Franck Touret, Magali Gilles, Karine Barral, Antoine Nougairède, Etienne Decroly, Xavier de Lamballerie, Bruno Coutard. (2020) In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication, [10.1101/2020.04.03.023846] |
| 213. Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek. (2020) Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection, [10.21203/rs.3.rs-23951/v1] |
| 214. Pérez-Areales FJ, Turcu AL, Barniol-Xicota M, Pont C, Pivetta D, Espargaró A, Bartolini M, De Simone A, Andrisano V, Pérez B, Sabate R, Sureda FX, Vázquez S, Muñoz-Torrero D.. (2019) A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors., 180 [PMID:31351393] [10.1016/j.ejmech.2019.07.051] |
| 215. Tang YW, Shi CJ, Yang HL, Cai P, Liu QH, Yang XL, Kong LY, Wang XB.. (2019) Synthesis and evaluation of isoprenylation-resveratrol dimer derivatives against Alzheimer's disease., 163 [PMID:30529634] [10.1016/j.ejmech.2018.11.040] |
| 216. Chen Y, Wu B, Hao Y, Liu Y, Zhang Z, Tian C, Ning X, Guo Y, Liu J, Wang X.. (2019) Structure-activity relationship studies of (E)-3,4-dihydroxystyryl alkyl sulfones as novel neuroprotective agents based on improved antioxidant, anti-inflammatory activities and BBB permeability., 171 [PMID:30928712] [10.1016/j.ejmech.2019.03.044] |
| 217. Wang W, Wu Y, Yang K, Wu C, Tang R, Li H, Chen L.. (2019) Synthesis of novel andrographolide beckmann rearrangement derivatives and evaluation of their HK2-related anti-inflammatory activities., 173 [PMID:31009914] [10.1016/j.ejmech.2019.04.022] |
| 218. Mathew B, Baek SC, Grace Thomas Parambi D, Pil Lee J, Joy M, Annie Rilda PR, Randev RV, Nithyamol P, Vijayan V, Inasu ST, Mathew GE, Lohidakshan KK, Kumar Krishnan G, Kim H.. (2018) Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitors., 9 (11): [PMID:30568755] [10.1039/C8MD00399H] |
| 219. Lopes JPB, Silva L, Ceschi MA, Lüdtke DS, Zimmer AR, Ruaro TC, Dantas RF, de Salles CMC, Silva-Jr FP, Senger MR, Barbosa G, Lima LM, Guedes IA, Dardenne LE.. (2019) Synthesis of new lophine-carbohydrate hybrids as cholinesterase inhibitors: cytotoxicity evaluation and molecular modeling., 10 (12): [PMID:32904099] [10.1039/C9MD00358D] |
| 220. Wang W, Wu Y, Chen X, Zhang P, Li H, Chen L.. (2019) Synthesis of new ent-labdane diterpene derivatives from andrographolide and evaluation of their anti-inflammatory activities., 162 [PMID:30419492] [10.1016/j.ejmech.2018.11.002] |
| 221. Lu Q, Li HB, Pang QQ, Zhang WY, Su ZZ, Pan DB, Yao XS, Yu Y.. (2019) New phenylpropanoid allopyranosides from the rhizomes of Cimicifuga dahurica., 29 (14): [PMID:31126853] [10.1016/j.bmcl.2019.05.011] |
| 222. Hu J, Pan T, An B, Li Z, Li X, Huang L.. (2019) Synthesis and evaluation of clioquinol-rolipram/roflumilast hybrids as multitarget-directed ligands for the treatment of Alzheimer's disease., 163 [PMID:30553143] [10.1016/j.ejmech.2018.12.013] |
| 223. Di Pietro O, Alencar N, Esteban G, Viayna E, Szałaj N, Vázquez J, Juárez-Jiménez J, Sola I, Pérez B, Solé M, Unzeta M, Muñoz-Torrero D, Luque FJ.. (2016) Design, synthesis and biological evaluation of N-methyl-N-[(1,2,3-triazol-4-yl)alkyl]propargylamines as novel monoamine oxidase B inhibitors., 24 (20): [PMID:27396685] [10.1016/j.bmc.2016.06.045] |
| 224. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
| 225. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
| 226. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
| 227. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
| 228. Johannes Zuegg, Alysha Elliott, Maite Amado, Emma Cowie, Ali Hinton, Geraldine Kaeslin, Angela Kavanagh, Anne Kunert, Gabriell Lowe, Soumya Ramu, Janet Reid, Robin Trauer, Mathilde Desselle, Ruth Neale, Karl Hansford, Mark Blascovich, Matthew Cooper. CO-ADD screening of NIH (USA) - Clinical Collection, [10.6019/CHEMBL4513141] |
| 229. Unpublished dataset, |
| 230. Gurr JR, O'Donnell TJ, Luo Y, Yoshida WY, Hall ML, Mayer AMS, Sun R, Williams PG.. (2020) 6-Deoxy- and 11-Hydroxytolypodiols: Meroterpenoids from the Cyanobacterium HT-58-2., 83 (5): [PMID:32282204] [10.1021/acs.jnatprod.9b00844] |
| 231. Li Q, Xing S, Chen Y, Liao Q, Xiong B, He S, Lu W, Liu Y, Yang H, Li Q, Feng F, Liu W, Chen Y, Sun H.. (2020) Discovery and Biological Evaluation of a Novel Highly Potent Selective Butyrylcholinsterase Inhibitor., 63 (17): [PMID:32787113] [10.1021/acs.jmedchem.0c01129] |
| 232. Ellen Van Damme. (2021) Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity, [10.6019/CHEMBL4651402] |
| 233. Xu J,Zhou L,Sun L,Wang Z,Wang Y,Wang Y,He X. (2020) 3α-Angeloyloxy-ent-kaur-16-en-19-oic Acid Isolated from Wedelia trilobata L. Alleviates Xylene-Induced Mouse Ear Edema and Inhibits NF-κB and MAPK Pathway in LPS-Stimulated Macrophages., 83 (12): [PMID:33306388] [10.1021/acs.jnatprod.0c00990] |
| 234. Wang, Xiao-Bing, Yin, Fu-Cheng, Huang, Ming, Jiang, Neng, Lan, Jin-Shuai, Kong, Ling-Yi. (2020) Chromone and donepezil hybrids as new multipotent cholinesterase and monoamine oxidase inhibitors for the potential treatment of Alzheimer''s disease, 11 (2): [PMID:33479629] [10.1039/c9md00441f] |
| 235. Nunes IKDC,de Souza ET,Martins IRR,Barbosa G,Moraes Junior MO,Medeiros MM,Silva SWD,Balliano TL,da Silva BA,Silva PMR,Carvalho VF,Martins MA,Lima LM. (2020) Discovery of sulfonyl hydrazone derivative as a new selective PDE4A and PDE4D inhibitor by lead-optimization approach on the prototype LASSBio-448: In vitro and in vivo preclinical studies., 204 [PMID:32717478] [10.1016/j.ejmech.2020.112492] |
| 236. Salgin-Goksen U,Telli G,Erikci A,Dedecengiz E,Tel BC,Kaynak FB,Yelekci K,Ucar G,Gokhan-Kelekci N. (2021) New 2-Pyrazoline and Hydrazone Derivatives as Potent and Selective Monoamine Oxidase A Inhibitors., 64 (4.0): [PMID:33533632] [10.1021/acs.jmedchem.0c01504] |
| 237. Wei S,Chen W,Qin J,Huangli Y,Wang L,Shen Y,Tang H. (2016) Multitarget-directed oxoisoaporphine derivatives: Anti-acetylcholinesterase, anti-β-amyloid aggregation and enhanced autophagy activity against Alzheimer's disease., 24 (22.0): [PMID:27720328] [10.1016/j.bmc.2016.09.061] |
| 238. Zhang Z,Guo J,Cheng M,Zhou W,Wan Y,Wang R,Fang Y,Jin Y,Liu J,Xie SS. (2021) Design, synthesis, and biological evaluation of novel xanthone-alkylbenzylamine hybrids as multifunctional agents for the treatment of Alzheimer's disease., 213 [PMID:33476932] [10.1016/j.ejmech.2021.113154] |
| 239. Xie SS,Liu J,Tang C,Pang C,Li Q,Qin Y,Nong X,Zhang Z,Guo J,Cheng M,Tang W,Liang N,Jiang N. (2020) Design, synthesis and biological evaluation of rasagiline-clorgyline hybrids as novel dual inhibitors of monoamine oxidase-B and amyloid-β aggregation against Alzheimer's disease., 202 [PMID:32652406] [10.1016/j.ejmech.2020.112475] |
| 240. Singh YP, Shankar G, Jahan S, Singh G, Kumar N, Barik A, Upadhyay P, Singh L, Kamble K, Singh GK, Tiwari S, Garg P, Gupta S, Modi G.. (2021) Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease., 46 [PMID:34481338] [10.1016/j.bmc.2021.116385] |
| 241. Qu L, Ji L, Wang C, Luo H, Li S, Peng W, Yin F, Lu D, Liu X, Kong L, Wang X.. (2021) Synthesis and evaluation of multi-target-directed ligands with BACE-1 inhibitory and Nrf2 agonist activities as potential agents against Alzheimer's disease., 219 [PMID:33862517] [10.1016/j.ejmech.2021.113441] |
| 242. Liu W, Liu X, Tian L, Gao Y, Liu W, Chen H, Jiang X, Xu Z, Ding H, Zhao Q.. (2021) Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease., 222 [PMID:34098466] [10.1016/j.ejmech.2021.113554] |
| 243. Jiang X, Zhang Z, Zuo J, Wu C, Zha L, Xu Y, Wang S, Shi J, Liu XH, Zhang J, Tang W.. (2021) Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease., 223 [PMID:34371367] [10.1016/j.ejmech.2021.113735] |
| 244. Mambwe D, Kumar M, Ferger R, Taylor D, Njoroge M, Coertzen D, Reader J, van der Watt M, Birkholtz LM, Chibale K.. (2021) Structure-Activity Relationship Studies Reveal New Astemizole Analogues Active against Plasmodium falciparum In Vitro., 12 (8.0): [PMID:34413963] [10.1021/acsmedchemlett.1c00328] |
| 245. Kennedy BJ, Lato AM, Fisch AR, Burke SJ, Kirkland JK, Prevatte CW, Dunlap LE, Smith RT, Vogiatzis KD, Collier JJ, Campagna SR.. (2021) Potent Anti-Inflammatory, Arylpyrazole-Based Glucocorticoid Receptor Agonists That Do Not Impair Insulin Secretion., 12 (10.0): [PMID:34676039] [10.1021/acsmedchemlett.1c00379] |
| 246. Tang JJ, Wang MR, Dong S, Huang LF, He QR, Gao JM.. (2021) 1,10-Seco-Eudesmane sesquiterpenoids as a new type of anti-neuroinflammatory agents by suppressing TLR4/NF-κB/MAPK pathways., 224 [PMID:34315042] [10.1016/j.ejmech.2021.113713] |
| 247. Zhang J, Li Y, Meng G, Lu K, Yan J, Wu J, Li P, Luo L, Chen X, Zhao X, Qiu F.. (2022) SILAC-based chemoproteomics reveals a neoligan analogue as an anti-inflammatory agent targeting IRGM to ameliorate cytokine storm., 241 [PMID:35970074] [10.1016/j.ejmech.2022.114659] |
| 248. Sun X, Wang Y, Lei Z, Yue S, Chen L, Sun J.. (2022) Development of 5-hydroxyl-1-azabenzanthrone derivatives as dual binding site and selective acetylcholinesterase inhibitors., 234 [PMID:35303485] [10.1016/j.ejmech.2022.114210] |
| 249. Lato AM, Burke SJ, Ducote MP, Kennedy BJ, Collier JJ, Campagna SR.. (2022) Stereoisomers of an Aryl Pyrazole Glucocorticoid Receptor Agonist Scaffold Elicit Differing Anti-inflammatory Responses., 13 (9.0): [PMID:36105346] [10.1021/acsmedchemlett.2c00299] |
| 250. Xi M, Feng C, Du K, Lv W, Du C, Shen R, Sun H.. (2022) Design, synthesis, biological evaluation and molecular modeling of N-isobutyl-N-((2-(p-tolyloxymethyl)thiazol-4yl)methyl)benzo[d][1,3] dioxole-5-carboxamides as selective butyrylcholinesterase inhibitors., 61 [PMID:35124202] [10.1016/j.bmcl.2022.128602] |
| 251. Zhang M, Wang F, Ding W, Xu Z, Li X, Tian D, Zhang Y, Tang J.. (2022) Synthesis of sorbicillinoid analogues with anti-inflammation activities., 54 [PMID:34971877] [10.1016/j.bmc.2021.116589] |
| 252. Ren B, Guo C, Liu RZ, Bian ZY, Liu RC, Huang LF, Tang JJ.. (2022) Imidazolylacetophenone oxime-based multifunctional neuroprotective agents: Discovery and structure-activity relationships., 228 [PMID:34875520] [10.1016/j.ejmech.2021.114031] |
| 253. Nozal V, Martínez-González L, Gomez-Almeria M, Gonzalo-Consuegra C, Santana P, Chaikuad A, Pérez-Cuevas E, Knapp S, Lietha D, Ramírez D, Petralla S, Monti B, Gil C, Martín-Requero A, Palomo V, de Lago E, Martinez A, Martinez A.. (2022) TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy., 65 (2.0): [PMID:34978799] [10.1021/acs.jmedchem.1c01942] |
| 254. Turcu AL, Companys-Alemany J, Phillips MB, Patel DS, Griñán-Ferré C, Loza MI, Brea JM, Pérez B, Soto D, Sureda FX, Kurnikova MG, Johnson JW, Pallàs M, Vázquez S.. (2022) Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer's disease., 236 [PMID:35453065] [10.1016/j.ejmech.2022.114354] |
| 255. Keller M, Fankhauser S, Giezendanner N, König M, Keresztes F, Danton O, Fertig O, Marcourt L, Hamburger M, Butterweck V, Potterat O.. (2021) Saponins from Saffron Corms Inhibit the Gene Expression and Secretion of Pro-Inflammatory Cytokines., 84 (3.0): [PMID:33600177] [10.1021/acs.jnatprod.0c01220] |
| 256. Bai R, Yao C, Zhong Z, Ge J, Bai Z, Ye X, Xie T, Xie Y.. (2021) Discovery of natural anti-inflammatory alkaloids: Potential leads for the drug discovery for the treatment of inflammation., 213 [PMID:33454546] [10.1016/j.ejmech.2021.113165] |
| 257. Sharma S, Kumar D, Singh G, Monga V, Kumar B.. (2020) Recent advancements in the development of heterocyclic anti-inflammatory agents., 200 [PMID:32485533] [10.1016/j.ejmech.2020.112438] |
| 258. Liu P, Cheng M, Guo J, Cao D, Luo J, Wan Y, Fang Y, Jin Y, Xie SS, Liu J.. (2023) Dual functional antioxidant and butyrylcholinesterase inhibitors for the treatment of Alzheimer's disease: Design, synthesis and evaluation of novel melatonin-alkylbenzylamine hybrids., 78 [PMID:36580744] [10.1016/j.bmc.2022.117146] |
| 259. Sutherland JJ, Yonchev D, Fekete A, Urban L.. (2023) A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs., 14 (1): [PMID:37468498] [10.1038/s41467-023-40064-9] |
| 260. European Medicines Agency, |
